Bruker Corporation (BRKR)
Nasdaq · Healthcare · Medical Devices
$63.86+0.98%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $9.7B
- Forward P/E
- 26.7
- Dividend yield
- 0.3%
- 52-week range
- $32.37 – $66.98
- 52-week change
- +82.99%
- EPS (trailing)
- −$0.70
- Analyst rating
- 2.2 Buy
- Next earnings
- Nov 3, 2026
Fiscal year to Dec 2025
- Revenue
- $3.4B (+2.08%)
- Net income
- −$8.3M
- Operating margin
- 2.0%
- Diluted EPS
- −$0.15
- Free cash flow
- $43.3M
From the company’s annual report on SEC EDGAR.
About Bruker Corporation
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions.
Headquarters: Billerica, United States · 11,085 employees · bruker.com